Visium Technologies Inc (VISM): lets see if we can break that 16 resista...

hb90 · 2014-10-03T12:13:33.0730000Z

lets see if we can break that 16 resistance today. hopefully it becomes our new support! good luck today everyone! $NSEH

Play Episode

5min

Proactive - Interviews for investors

Major investment: AuKing’s $5M earn-in deal

AuKing Mining Ltd managing director Paul Williams joins Proactive’s Jonathan Jackson to discuss the company’s right to earn up to a 50% stake in Orion Resources Pty Ltd, which is acquiring the Cloncurry Gold Project in northwest Queensland. The agreement extends a prior deal allowing AuKing to earn a 15% stake through $1.5 million in project-related expenditure. Under the new terms, AuKing must invest $5 million in project development by June 30, 2027. Orion is finalising the acquisition of the Cloncurry Gold Project, the Lorena processing plant, and the Mt Freda/Golden Mile deposits. The company is also considering processing material from the Tick Hill mine and tailings. AuKing’s investment will support exploration, drilling, and resource estimation work, particularly at Mt Freda/Golden Mile, as well as refurbishment of the Lorena plant. Upon completing the $5 million earn-in, AuKing and Orion will form an incorporated joint venture, with AuKing holding a 50% share. If AuKing does not meet the expenditure requirement, its interest will lapse. Orion will fund the purchase of the Cloncurry Gold Project independently, and AuKing has no further automatic acquisition rights beyond the 50% stake. ➡️ Watch the full interview for more insights! 🔔 Don’t forget to like, subscribe, and turn on notifications for more updates from Proactive. #AuKingMining #GoldMining #MiningStocks #CloncurryGold #OrionResources #Investing #ASX #GoldExploration #MiningUpdates #GoldProduction

Proactive - Interviews for investors

KEFI Gold and Copper gets green light to progress with Tulu Kapi project in Ethiopia

KEFI Gold and Copper PLC executive chairman Harry Anagnostaras-Adams talked with Proactive about a major milestone for the company’s flagship Tulu Kapi gold project in Ethiopia. He described the latest announcement as the most significant since KEFI decided to focus on the Arabian Nubian Shield in 2008. Anagnostaras-Adams confirmed that all stakeholders in the project have now given the green light, marking the start of the next phase. He emphasised that there is no risk of being blocked, as land resettlement is progressing with the support of the local community. The process, involving thousands of people, is expected to be completed within a month, alongside final project preparations. He reiterated that the company has passed the “point of no return” and is now expediting the project’s launch. Investors seeking more details on KEFI’s technical, environmental, and financial studies can find extensive information on the company’s website: https://www.kefi-goldandcopper.com For more updates on KEFI Gold and Copper and other industry developments, visit Proactive’s YouTube channel. Don’t forget to like this video, subscribe, and turn on notifications for the latest insights. Relevant Hashtags #KEFIGold #GoldMining #CopperMining #TuluKapi #EthiopiaMining #MiningInvestment #GoldStocks #ResourceSector #MiningUpdates #ProactiveInvestors

Proactive - Interviews for investors

Empire Metals MD on high-purity titanium breakthrough

Empire Metals Ltd (AIM:EEE) managing director Shaun Bunn talked with Proactive about the company's latest metallurgical test results at the Pitfield project. The test work delivered an impressive 91.6% purity titanium dioxide compound—achieved on the first attempt. Bunn emphasised that this high-grade product is free from deleterious contaminants, making it suitable for further processing into titanium sponge metal or premium-grade titanium pigments. He explained that the team successfully extracted and refined the titanium-bearing minerals using gravity separation, flotation, and acid digestion techniques. The company is now focused on optimising its processing flow sheet and scaling up test work. Recent bulk metallurgical sample collections at Pitfield will support larger-scale testing, with the goal of producing more of this high-grade product for market analysis. Bunn also highlighted that the simplicity of Pitfield's mineral composition, free from heavy metals or radioactive elements, has contributed to the rapid progress in refining processes. With further purification testing ahead, Empire Metals is poised to advance its titanium strategy. For more insights from this interview, visit Proactive’s YouTube channel. Don't forget to like, subscribe, and turn on notifications for future updates. #EmpireMetals #Titanium #Mining #PitfieldProject #Metallurgy #TitaniumDioxide #MineralProcessing #MiningStocks #TitaniumSponge #Investing

Proactive - Interviews for investors

Daniel Tillett on Race Oncology’s drug advancements

Race Oncology Ltd CEO and managing director Daniel Tillett talked with Proactive about the company’s development of a reformulated cancer drug aimed at improving chemotherapy treatment. Tillett discussed the challenges of chemotherapy, including severe side effects, and how Race Oncology is working to minimise these risks while enhancing treatment effectiveness. He explained that the company has taken an older, previously approved drug and developed a new formulation that improves its delivery while protecting patients from heart-related side effects. This new approach, which involves combining the reformulated drug with anthracyclines, aims to enhance cancer treatment while reducing long-term health risks for patients. Tillett highlighted the significant market potential for the company’s drug, given that anthracyclines remain a cornerstone of cancer treatment. The company is now advancing into clinical trials, with results expected to provide key insights into the drug’s effectiveness in humans. Watch the full interview to learn more about Race Oncology’s latest advancements. Don’t forget to like this video, subscribe to Proactive’s YouTube channel, and turn on notifications for more updates on cutting-edge biotech developments. #RaceOncology #CancerTreatment #Biotech #Chemotherapy #Pharmaceuticals #DrugDevelopment #ClinicalTrials #OncologyResearch #Investing #CancerResearch #Cardioprotection

Followers	41
Posts	2179
Boards Moderated	0
Alias Born	02/15/2014

Volume:	4,616,136
Day Range:	0.0012 - 0.0019
Bid:	0.0012
Ask:	0.0018
Last Trade Time:	3:50:49 PM EDT
Total Trades:	31

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

VISM Detailed Quote

Recent VISM News

More VISM News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent VISM News

Go Ad-Free